259 related articles for article (PubMed ID: 23799286)
1. Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.
Sadraei NH; Dahiya S; Chao ST; Murphy ES; Osei-Boateng K; Xie H; Suh JH; Peereboom DM; Stevens GH; Ahluwalia MS
Am J Clin Oncol; 2015 Jun; 38(3):304-10. PubMed ID: 23799286
[TBL] [Abstract][Full Text] [Related]
2. Effect of bevacizumab on radiation necrosis of the brain.
Gonzalez J; Kumar AJ; Conrad CA; Levin VA
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):323-6. PubMed ID: 17236958
[TBL] [Abstract][Full Text] [Related]
3. Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis.
Khan M; Zhao Z; Arooj S; Liao G
BMC Cancer; 2021 Feb; 21(1):167. PubMed ID: 33593308
[TBL] [Abstract][Full Text] [Related]
4. Targeted intraarterial anti-VEGF therapy for medically refractory radiation necrosis in the brain.
Dashti SR; Spalding A; Kadner RJ; Yao T; Kumar A; Sun DA; LaRocca R
J Neurosurg Pediatr; 2015 Jan; 15(1):20-5. PubMed ID: 25360851
[TBL] [Abstract][Full Text] [Related]
5. Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.
Narita Y
Jpn J Clin Oncol; 2013 Jun; 43(6):587-95. PubMed ID: 23585688
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery.
Boothe D; Young R; Yamada Y; Prager A; Chan T; Beal K
Neuro Oncol; 2013 Sep; 15(9):1257-63. PubMed ID: 23814264
[TBL] [Abstract][Full Text] [Related]
7. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.
Torcuator R; Zuniga R; Mohan YS; Rock J; Doyle T; Anderson J; Gutierrez J; Ryu S; Jain R; Rosenblum M; Mikkelsen T
J Neurooncol; 2009 Aug; 94(1):63-8. PubMed ID: 19189055
[TBL] [Abstract][Full Text] [Related]
8. Clinical Variables for Prediction of the Therapeutic Effects of Bevacizumab Monotherapy in Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis.
Li Y; Huang X; Jiang J; Hu W; Hu J; Cai J; Rong X; Cheng J; Xu Y; Wu R; Luo J; Tang Y
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):621-629. PubMed ID: 29413276
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.
Lubelski D; Abdullah KG; Weil RJ; Marko NF
J Neurooncol; 2013 Dec; 115(3):317-22. PubMed ID: 24005770
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.
Levin VA; Bidaut L; Hou P; Kumar AJ; Wefel JS; Bekele BN; Grewal J; Prabhu S; Loghin M; Gilbert MR; Jackson EF
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1487-95. PubMed ID: 20399573
[TBL] [Abstract][Full Text] [Related]
11. [Bevacizumab for the treatment of cerebral radionecrosis].
Gronier S; Bourg V; Frenay M; Cohen M; Mondot L; Thomas P; Lebrun C
Rev Neurol (Paris); 2011 Apr; 167(4):331-6. PubMed ID: 21420137
[TBL] [Abstract][Full Text] [Related]
12. A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema.
Wang Y; Wang E; Pan L; Dai J; Zhang N; Wang X; Liu X; Mei G; Sheng X
J Neurooncol; 2014 Sep; 119(2):369-76. PubMed ID: 24879376
[TBL] [Abstract][Full Text] [Related]
13. Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: case report and review of the literature.
Sanborn MR; Danish SF; Rosenfeld MR; O'Rourke D; Lee JY
Clin Neurol Neurosurg; 2011 Nov; 113(9):798-802. PubMed ID: 21906869
[No Abstract] [Full Text] [Related]
14. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET.
Furuse M; Nonoguchi N; Kawabata S; Yoritsune E; Takahashi M; Inomata T; Kuroiwa T; Miyatake S
Jpn J Clin Oncol; 2013 Mar; 43(3):337-41. PubMed ID: 23303838
[TBL] [Abstract][Full Text] [Related]
15. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
Wang Y; Pan L; Sheng X; Mao Y; Yao Y; Wang E; Zhang N; Dai J
Eur J Med Res; 2012 Aug; 17(1):25. PubMed ID: 22913802
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
Yonezawa S; Miwa K; Shinoda J; Nomura Y; Asano Y; Nakayama N; Ohe N; Yano H; Iwama T
J Neurooncol; 2014 Aug; 119(1):101-9. PubMed ID: 24789256
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab reverses cerebral radiation necrosis.
Wong ET; Huberman M; Lu XQ; Mahadevan A
J Clin Oncol; 2008 Dec; 26(34):5649-50. PubMed ID: 18981459
[No Abstract] [Full Text] [Related]
18. Bevacizumab as a treatment option for radiation-induced cerebral necrosis.
Matuschek C; Bölke E; Nawatny J; Hoffmann TK; Peiper M; Orth K; Gerber PA; Rusnak E; Lammering G; Budach W
Strahlenther Onkol; 2011 Feb; 187(2):135-9. PubMed ID: 21336713
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.
Zhuang H; Yuan X; Chang JY; Song Y; Wang J; Yuan Z; Wang X; Wang P
Oncotarget; 2016 Jul; 7(30):48842-48849. PubMed ID: 26934327
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab in the treatment of radiation injury for children with central nervous system tumors.
Dahl NA; Liu AK; Foreman NK; Widener M; Fenton LZ; Macy ME
Childs Nerv Syst; 2019 Nov; 35(11):2043-2046. PubMed ID: 31367784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
